Article
Validation of ICC hierarchical classification in secondary AML.
Blood advances - 26 May 2026
Attardi Enrico, Cipriani Marta, Guarnera Luca, Savi Arianna, Fabiani Emiliano, Mallegni Flavia, Moretti Federico, Silvestrini Giorgia, Awada Hussein, Durmaz Arda, Ferrari Ivan, Maggioni Giulia, Memoli Mara, Visconte Valeria, Venditti Adriano, Della Porta Matteo Giovanni, Gurnari Carmelo, Piciocchi Alfonso, Maciejewski Jaroslaw P, Voso Maria Teresa
Abstract excerpt
ABSTRACT: Secondary acute myeloid leukemia (AML) comprises heterogeneous entities, unified by poor prognosis. We evaluated the associations of genetic profiles with blast counts and patients' history in a cohort of 924 patients with myelodysplastic syndrome (MDS)/AML or AML, classified according to the International Consensus Classification (ICC). The cohort included 109 patients with "mutated TP53," 497 with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
